One group has reported that increased β cell expression of HRD1 (such as may occur in type 2 diabetes or in mouse models of the disease) triggers impaired insulin secretion, whereas impaired ERAD capacity by HRD1 knockdown (KD) improves blood glucose control (13). The gene discussed is SYVN1; the disease is type 2 diabetes mellitus.